BACKGROUND Trachoma is the leading cause of preventable blindness worldwide. It is common in areas where people are socioeconomically deprived. Globally, approximately 1.2 billion people live in trachoma-endemic areas, in which, 40.6 million individuals have active trachoma and 8.2 million have trichiasis. According to the World Health Organization's 2007 report, globally close to 1.3 million p...

Trachoma, a blinding eye disease caused by repeated and prolonged infection with Chlamydia trachomatis, is a significant public health problem for sub-Saharan Africa. Tanzania has had a National Trachoma Task Force since 1999, working on trachoma control in endemic districts. The objective of this study was twofold: first, to determine the current status of infection and clinical trachoma in th...

BACKGROUND A high proportion of active trachoma infection in children of Car-Nicobar Island was reported through the Trachoma Rapid Assessment survey conducted in year 2010 by the same researchers. Annual mass drug treatment with azithromycin was administered from years 2010-12 to all individuals residing in this island for reducing the burden of active trachoma infection. A cross-sectional pre...

Former US President Jimmy Carter, speaking at the 15th anniversary of Pfizer’s donation of Zithromax® in New York on 5th November 2013, said: "With the help of Pfizer, we are trying to eliminate blinding trachoma from the face of the earth by 2020. I think we have a very good chance of reaching this goal." During the past 15 years, Pfi zer – through the International Trachoma Initiative (ITI) –...

Endemic trachoma continues to exist in remote Aboriginal communities in Australia. The National Trachoma Surveillance and Reporting Unit, established in 2006, is responsible for the collation, analysis and reporting of trachoma prevalence data and the documentation of trachoma control strategies in Australia. Data were collected from Aboriginal communities designated at-risk for endemic trachom...

BACKGROUND Trachoma is thought to be endemic over large parts of Southern Sudan, but empirical evidence is limited. While some areas east of the Nile have been identified as highly endemic, few trachoma surveys have been conducted in the remainder of the country. This study aimed to determine whether trachoma constitutes a problem to public health in Northern Bahr-el-Ghazal and Unity State, bot...

Chlamydiae are obligate intracellular bacteria causing mucosal infections. The leading agent Chlamydia trachomatis causes three clinical features in eyes: trachoma, neonatal, and adult inclusion conjunctivitis. A rare chlamydial conjunctivitis form called Lymphogranuloma Venereum can be venereally transmitted. Seldomly psittaci pneumonia may cause follicular Trachoma, the most sight-threatening...

Background: Worldwide, 2.2 million people are visually impaired, and nearly 1.2 irreversibly blind because of Trachoma. Women girls particularly vulnerable to infection, as they often the primary caregivers children, children greatest source infection with As prevention option Trachoma, World Health Organization recommends Facial cleanliness (F), Environmental Improvement (E), Antibiotics (A) S...

Trachoma, the second leading cause of blindness world wide, continues to be hyperendemic in many areas of Africa, Asia, and the Middle East. Caused by an ocular infection with Chlamydia trachomatis, this chronic conjunctivitis results in more blindness than any other infectious eye disease. Once endemic in most countries, trachoma has largely disappeared from Europe and the Americas. Because of...

BACKGROUND Trachoma is an infectious eye disease caused by Chlamydia trachomatis, which is the leading infectious cause of blindness worldwide. In areas where trachoma is endemic, active trachoma is common among preschool-aged children, with varying magnitude. This study aimed to estimate the prevalence of active trachoma and associated risk factors among preschool-aged children in Dembia Distr...